Efficacy Profiles of Antimicrobials Evaluated against Staphylococcus Species Isolated from Canine Clinical Specimens

Daniel Nenene Qekwana1, Agricola Odoi2, James Wabwire Oguttu3

  • 1Section of Veterinary Public Health, Department of Paraclinical Sciences, Faculty of Veterinary Science, University of Pretoria, Pretoria 0110, South Africa.

Insights

Antimicrobial efficacy profiles cluster by drug class, revealing cross-resistance patterns. Laboratories can reduce antimicrobial susceptibility testing costs by selecting one agent per class.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Cross-resistance among antimicrobials, whether related or unrelated, poses a significant challenge in infectious disease management.
  • Understanding antimicrobial efficacy profiles and their associations is crucial for optimizing treatment strategies and diagnostic testing.

Purpose of the Study:

  • To investigate the associations between antimicrobial efficacy profiles and the clustering of eleven antimicrobial agents.
  • To analyze antimicrobial susceptibility profiles in *Staphylococcus* species using a multivariate approach.

Main Methods:

  • A multivariate approach was employed, analyzing susceptibility data from 382 *Staphylococcus* isolates against 15 antimicrobials via disc diffusion.
  • Tetrachoric correlation coefficients were computed to assess correlations in antimicrobial efficacy profiles.
  • Principal components analysis and factor analysis were utilized to determine the clustering of antimicrobial susceptibility profiles.

Main Results:

  • Strong correlations in efficacy profiles were observed among aminoglycosides, penicillins, fluoroquinolones, and lincosamides.
  • Three main factors emerged, with Factor 1 linked to enrofloxacin, gentamicin, tylosin, and ampicillin; Factor 2 to clindamycin, lincomycin-spectinomycin, and co-trimoxazole; and Factor 3 to amoxicillin-clavulanic acid and cephalothin.
  • Antimicrobials within the same class generally exhibited similar efficacy profiles.

Conclusions:

  • Antimicrobial agents tend to cluster based on their efficacy profiles, often aligning with their respective drug classes.
  • Laboratories can optimize antimicrobial susceptibility testing by selecting a single representative antimicrobial agent from each identified efficacy group, thereby reducing costs.